VitamFero vitamfero.com


VitamFero holds an innovative and proprietary technology developed and patented conjointly by INRA, François-Rabelais University of Tours and CNRS. This patented technology is based on a live and attenuated Toxoplasma gondii strain, the parasite responsible for toxoplasmosis. This strain, called "Toxo KO", was obtained by dual deletions (hence Knock-Out or KO) of mic1 and mic3 genes through a homologous recombination procedure. Despite the lack of MIC1 and MIC3 protein expression, the "Toxo ...Show all

VitamFero holds an innovative and proprietary technology developed and patented conjointly by INRA, François-Rabelais University of Tours and CNRS. This patented technology is based on a live and attenuated Toxoplasma gondii strain, the parasite re...Show all

Company (Alive / Active)

Phone:

Fax:

4, rue Pierre Fontaine

Evry, 91058
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
VitamFero $6.7M May 28, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related VitamFero Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.